More than one out of three people have pre-diabetes, characterized by abnormal blood sugar levels not yet in the diabetes range – and yet associated with significant increases in eye, kidney and neuropathic diseases, and risk of cardiovascular death.
Lupin wins first FDA approval for generic version of Boehringer Ingelheim blockbuster Spiriva
Indian drugmaker Lupin today said it won FDA approval for the first generic version of Spiriva, a blockbuster COPD drug from Boehringer Ingelheim. The generic,